Large-scale testing (Phase 3)Study completedNCT01298219
What this trial is testing
Opioid-induced Bowel Dysfunction (OBD) Pivotal Assessment of Lubiprostone (OPAL)
Who this might be right for
Opioid-induced Bowel Dysfunction
Sucampo Pharma Americas, LLC 439